Does ROZANOLIXIZUMAB Cause Injection site bruising? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Injection site bruising have been filed in association with ROZANOLIXIZUMAB (RYSTIGGO). This represents 1.7% of all adverse event reports for ROZANOLIXIZUMAB.
5
Reports of Injection site bruising with ROZANOLIXIZUMAB
1.7%
of all ROZANOLIXIZUMAB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Injection site bruising From ROZANOLIXIZUMAB?
Of the 5 reports, 1 (20.0%) resulted in death, 2 (40.0%) required hospitalization.
Is Injection site bruising Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROZANOLIXIZUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ROZANOLIXIZUMAB Cause?
Myasthenia gravis (158)
Headache (64)
Drug ineffective (54)
Diarrhoea (41)
Asthenia (36)
Fatigue (34)
Dyspnoea (29)
Nausea (25)
Fall (22)
Therapeutic response shortened (22)
What Other Drugs Cause Injection site bruising?
ETANERCEPT (7,734)
ADALIMUMAB (7,249)
EVOLOCUMAB (4,409)
TERIPARATIDE (4,405)
DUPILUMAB (4,332)
TIRZEPATIDE (2,665)
SECUKINUMAB (1,969)
DULAGLUTIDE (1,832)
HUMIRA (1,623)
EXENATIDE (1,299)
Which ROZANOLIXIZUMAB Alternatives Have Lower Injection site bruising Risk?
ROZANOLIXIZUMAB vs ROZANOLIXIZUMAB-NOLI
ROZANOLIXIZUMAB vs RUBIDIUM RB-82
ROZANOLIXIZUMAB vs RUCAPARIB
ROZANOLIXIZUMAB vs RUCAPARIB CAMSYLATE
ROZANOLIXIZUMAB vs RUFINAMIDE